{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:23:06Z","timestamp":1740147786183,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12070-020-02104-4","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:02:34Z","timestamp":1598943754000},"page":"320-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low Dose Intratympanic Gentamicin in M\u00e9ni\u00e8re\u2019s Disease"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-9720","authenticated-orcid":false,"given":"Bini","family":"Faizal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsha","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"5","key":"2104_CR1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.otc.2004.06.002","volume":"37","author":"J Carey","year":"2004","unstructured":"Carey J (2004) Intratympanic gentamicin for the treatment of M\u00e9ni\u00e8re\u2019s disease and other forms of peripheral vertigo. Otolaryngol Clin N Am 37(5):1075\u20131090 (PMID: 15474112)","journal-title":"Otolaryngol Clin N Am"},{"issue":"3","key":"2104_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","volume":"113","author":"TA Balkany","year":"1995","unstructured":"HEARING CO, Balkany TA, Gates GA, Goldenberg RA, Meyerhoff WL, House JW et al (1995) Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Head Neck Surg 113(3):181\u2013185 (PMID: 7675476)","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2104_CR3","volume-title":"TExtbool of otolaryngology","author":"MM Paparella","year":"1980","unstructured":"Paparella MM, Shumrick DA (1980) TExtbool of otolaryngology, vol 3. WB Saunders Company, Philadelphia"},{"issue":"1","key":"2104_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00005537-199701000-00017","volume":"107","author":"CL Driscoll","year":"1997","unstructured":"Driscoll CL, Kasperbauer JL, Facer GW, Harner SG, Beatty CW (1997) Low-dose intratympanic gentamicin and the treatment of M\u00e9ni\u00e8re\u2019s disease: preliminary results. Laryngosc 107(1):83\u201389 (PMID: 9001270)","journal-title":"Laryngosc"},{"issue":"7","key":"2104_CR5","first-page":"979","volume":"89","author":"L Kasemsuwan","year":"2006","unstructured":"Kasemsuwan L, Jariengprasert C, Chaturapatranont S (2006) Transtympanic gentamicin treatment in M\u00e9ni\u00e8re\u2019s disease: a preliminary report. J Med Assoc Thail 89(7):979 (PMID: 16881430)","journal-title":"J Med Assoc Thail"},{"issue":"4","key":"2104_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","volume":"25","author":"SH Chia","year":"2004","unstructured":"Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for M\u00e9ni\u00e8re\u2019s disease: a meta-analysis. Otol Neurotol 25(4):544\u2013552 (PMID: 15241234)","journal-title":"Otol Neurotol"},{"issue":"5","key":"2104_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/0194599813520398","volume":"150","author":"AP Casani","year":"2014","unstructured":"Casani AP, Cerchiai N, Navari E, Dallan I, Piaggi P, Sellari-Franceschini S (2014) Intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease: short- and long-term follow-up of two regimens of treatment. Otolaryngol Head Neck Surg 150(5):847\u2013852 (PMID: 24477826)","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"2104_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.amjoto.2010.07.021","volume":"32","author":"S Gode","year":"2011","unstructured":"Gode S, Celebisoy N, Akyuz A, Gulec F, Karapolat H, Bilgen C, Kirazli T (2011) Single-shot, low-dose intratympanic gentamicin in M\u00e9ni\u00e8re disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome. Am J Otolaryngol 32(5):412\u2013416 (PMID: 20851502)","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"2104_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/000164801300102879","volume":"121","author":"A Quaranta","year":"2001","unstructured":"Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I (2001) Intratympanic therapy for M\u00e9ni\u00e8re\u2019s disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol (Stockh) 121(3):387\u2013392 (PMID: 11425206)","journal-title":"Acta Otolaryngol (Stockh)"},{"issue":"8","key":"2104_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/00016480701762458","volume":"128","author":"RJ Postema","year":"2008","unstructured":"Postema RJ, Kingma CM, Wit HP, Albers FWJ, Van Der Laan BFAM (2008) Intratympanic gentamicin therapy for control of vertigo in unilateral Meni\u00e8re\u2019s disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol (Stockh) 128(8):876\u2013880 (PMID: 18607963)","journal-title":"Acta Otolaryngol (Stockh)"},{"issue":"2","key":"2104_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/00016480410016621","volume":"124","author":"R Stokroos","year":"2004","unstructured":"Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active M\u00e9ni\u00e8re\u2019s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol (Stockh) 124(2):172\u2013175 (PMID: 15072419)","journal-title":"Acta Otolaryngol (Stockh)"},{"issue":"sup558","key":"2104_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03655230701624889","volume":"127","author":"W-H Chung","year":"2007","unstructured":"Chung W-H, Whan Chung K, Ho Kim J, Cho Y-S, Hwa HS (2007) Effects of a single intratympanic gentamicin injection on M\u00e9ni\u00e8re\u2019s disease. Acta Otolaryngol (Stockh) 127(sup558):61\u201366 (PMID: 17882572)","journal-title":"Acta Otolaryngol (Stockh)"},{"issue":"6","key":"2104_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/01.mao.0000227663.79210.c1","volume":"27","author":"A Horii","year":"2006","unstructured":"Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M et al (2006) Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable M\u00e9ni\u00e8re\u2019s disease. Otol Neurotol 27(6):896\u2013900 (PMID: 16788414)","journal-title":"Otol Neurotol"},{"issue":"4","key":"2104_CR14","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/lary.25009","volume":"125","author":"YC Rah","year":"2015","unstructured":"Rah YC, Han JJ, Park J, Choi BY, Koo JW (2015) Management of intractable M\u00e9ni\u00e8re\u2019s disease after intratympanic injection of gentamicin. Laryngosc 125(4):972\u2013978. https:\/\/doi.org\/10.1002\/lary.25009","journal-title":"Laryngosc"},{"key":"2104_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-018-5260-5","author":"Q Wu","year":"2019","unstructured":"Wu Q, Li X, Sha Y, Dai C (2019) Clinical features and management of Meniere\u2019s disease patients with drop attacks. Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-018-5260-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2104_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/0971-7749.182284","volume":"22","author":"H Gayathri","year":"2016","unstructured":"Gayathri H, Rao SS (2016) Low dose intratympanic gentamicin for control of intractable vertigo. Indian J Otol 22:110\u2013118. https:\/\/doi.org\/10.4103\/0971-7749.182284","journal-title":"Indian J Otol"}],"container-title":["Indian Journal of Otolaryngology and Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12070-020-02104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12070-020-02104-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12070-020-02104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T19:44:23Z","timestamp":1661456663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12070-020-02104-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":16,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1007\/s12070-020-02104-4","relation":{},"ISSN":["2231-3796","0973-7707"],"issn-type":[{"type":"print","value":"2231-3796"},{"type":"electronic","value":"0973-7707"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No conflict of interest declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was reviewed and approved by the Institutional Ethics Committee of our institute, and they were in accordance with the ethical standards laid down in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All interventions and investigations were done with informed consent of the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}